ArticleHemaSphere2025

Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study.

André Baruchel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.